Abstract
Purpose: To compare T1DM as a risk factor for various complications of arthroscopic hip surgery, including infection, wound dehiscence, septic arthritis, heterotopic ossification, deep vein thrombosis (DVT), emergency department (ED) visits, readmission, need for a total hip replacement, and mortality. Methods: Utilizing deidentified patient records from the TriNetX database, this retrospective study analyzed 67,493 patients who underwent hip arthroscopy from January 1, 2018, to January 1, 2023. Patients were categorized into cohorts based on T1DM status, and propensity score matching was employed for age, gender, ethnicity, race, and comorbidities. Chi-square analysis and logistic regression were used to assess the relationship between T1DM and complications within 90 days post-surgery, as well as 1 and 2-year outcomes. Results: Patients with T1DM (n=5,997) exhibited significantly higher odds of infection, wound dehiscence, septic arthritis, DVT, ED visits, readmissions, and mortality within 90 days post-hip arthroscopy compared to those without T1DM (p<0.05). Similar trends were observed at 1 and 2 years, with increased odds of total hip replacement and mortality (p<0.05). Notably, T1DM patients had decreased odds of heterotopic ossification (p= 0.0003). Conclusion: Patients with T1DM demonstrated significantly elevated rates of postoperative complications, including infections, wound issues, and mortality, following hip arthroscopy.